Queen's University School of Kinesiology & Health Studies
Kingston, Ontario, K7L 3N6, Canada
Location status: Recruiting
NCT Number: NCT07441343
After approximately age 40 years, individuals experience a natural loss of muscle mass, strength, and physical function that is linked to higher risks of falls, disability, loss of independence, and mortality. These losses can also be a precursor to the development of frailty, which includes factors beyond impaired physical function such as cognitive impairment, psychological disorder, increased likelihood of hospitalization, need of long term-care, and mortality. Structured exercise-encompassing both resistance and aerobic training-is widely recognized as an effective lifestyle intervention for improving muscle health, cardiovascular capacity, and overall physical function in older adults. However, aging is accompanied by chronically elevated systemic inflammation, and although exercise remains highly beneficial, older adults exhibit a heightened inflammatory response to training and a diminished capacity for post-exercise recovery.
Polyphenols, a group of naturally occurring bioactive compounds, have been shown to possess both anti-inflammatory and antioxidant benefits, positively impacting recovery and health. Polyphenol supplementation, particularly when paired with structured exercise, may elicit synergistic improvements in physical performance through combined effects on oxidative stress, inflammation, and muscle recovery, making polyphenols a compelling adjunct strategy for mitigating sarcopenia. In pursuit of refining strategies that support healthy aging and preserve functional capacity in older adults, this study aimed to determine the feasibility of implementing a 12-week resistance and aerobic exercise program combined with dietary supplementation in older adults.
Participants will either consume a polyphenol blend or a placebo control of maltodextrin daily whilst undergoing 12 weeks of supervised resistance and aerobic exercise. Additionally, this study will test the hypothesis that polyphenol supplementation will augment the exercise-induced improvements in physical function and muscle health. Further, exploratory analyses of skeletal muscle biopsy and venous plasma samples will aid in elucidating the potential geroprotective effects of polyphenols at both cellular and molecular levels.
Interested in participating?
Request Info60 year and older
All sexes
Interventional
Not applicable
Kingston, Ontario, K7L 3N6, Canada
Location status: Recruiting
Life expectancy in Canada continues to rise, and by 2068 more than one-quarter of the population will be over the age of 65 years. Although Canadians are living longer, added years are not necessarily lived in good health. Aging is associated with increased sedentary behaviour, reduced physical performance, higher prevalence of chronic disease, and greater healthcare use. Sedentary behaviour, physical inactivity, and poor dietary habits accelerate age-related functional decline and contribute to chronic low-grade inflammation, a key driver of frailty, disability, and loss of independence in older adults. Exercise is strongly recommended to mitigate these risks, with clear dose-response benefits for all-cause and cardiovascular mortality; however, adherence can be limited, and age-related inflammation may blunt beneficial exercise adaptations. This underscores the need for accessible lifestyle strategies that support muscle function, physical performance, and healthy aging.
Polyphenols-naturally occurring bioactive compounds found in fruits and vegetables-have demonstrated anti-inflammatory and antioxidant effects relevant to exercise recovery and muscle adaptation. The investigational supplement used in this study (Phyto-P) contains a six-polyphenol blend including chlorogenic acid, chicoric acid, anthocyanins, and quercetin derivatives. Preclinical and human trials of individual polyphenols show reductions in inflammatory cytokines, improvements in antioxidant capacity, and attenuation of exercise-induced muscle damage. Despite these promising findings, it remains unknown whether a multi-polyphenol blend such as Phyto-P can enhance exercise-induced improvements in muscle strength, functional capacity, or molecular markers of skeletal muscle adaptation in older adults.
The purpose of this randomized, double-blind, placebo-controlled pilot feasibility trial is to determine whether it is practical to deliver a 12-week combined resistance band and aerobic exercise intervention with daily polyphenol supplementation in older adults. Feasibility outcomes-including recruitment, retention, exercise adherence, and supplement adherence-will determine whether a larger, fully powered efficacy trial is achievable. Secondary, exploratory outcomes will assess changes in physical function, muscular strength and power, skeletal muscle health and fiber-type distribution, cardiorespiratory fitness, self-reported well-being, and blood biomarkers, offering preliminary mechanistic insight to guide hypothesis generation for future studies.
Participants aged ≥60 years will be recruited from the Kingston community and complete screening, baseline assessments, a 12-week supervised exercise program paired with polyphenol or placebo supplementation, a midpoint assessment at week 6, and post-intervention testing that mirrors baseline procedures. The data generated from this pilot study will inform the design, methodology, and sample size requirements of future large-scale randomized controlled trials aimed at improving skeletal muscle health, physical function, and healthy aging through combined nutritional and exercise-based strategies.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Polyphenol Rich-Extract (Phyto-P) derived from Lactuca Sativa (red leaf lettuce). 12-Week daily consumption of 3g of Phyto-P (polyphenol-rich extract: chlorogenic acid (30.15 mg), chicoric acid (13.44 mg), 3,4-dicaffeoylquinic acid (8.43 mg), quercetin-3-O-glucoside (15.81 mg), quercetin-3-O-malonyl glucoside (33.00 mg), and anthocyanins (30.57 mg)) as capsules.
12-Week Daily consumption of 3g of maltodextrin consumed as capsules.
Resistance Band-Based Exercise: Participants will complete a dynamic warm up followed by eight exercises (squats, hip extensions, rows, chest press, split squats, calf raises, bicep curls, tricep extensions) each session, organized as four supersets of two exercises targeting both upper and lower body. Each exercise will be performed with a controlled three-second eccentric phase, with sets and repetitions gradually progressing from 2 × 8-12 to 3 × 12-14. Resistance will be increased using band color (thickness), and post-set Rate of Perceived Exertion (RPE) will guide individualized progression. Sessions will be conducted twice weekly for approximately 50 minutes.
Aerobic Stationary Cycling: Participants will perform stationary cycling twice weekly for approximately 50 minutes per session at 60% of peak work rate (WRpeak). Exercise intensity will be re-prescribed after mid-point testing to ensure continued progression and alignment with participants' current fitness level
Time frame: 18 months, 12 weeks
Retention is expressed as the percentage of participants who completed baseline testing, the 12-week intervention, and post-testing visits, relative to those who completed baseline testing but did not finish. Success is defined as at least 75% (≥30 of 40) completing the study while maintaining adherence above 75% for both exercise sessions and supplementation.
Time frame: 18 months
Number of participants recruited. Success is defined as recruitment of 40 participants across 18 months.
Time frame: -1 week, 6 weeks, 12 weeks
Change in leg-extensor peak torque measured by isometric dynamometry in Newton meters (Nm).
Time frame: -1 week, 6 weeks, 12 weeks
Change in leg-extensor isotonic power measured by dynamometry in Newton meters (Nm).
Time frame: week -1, week 6, week 12
Change in maximal handgrip strength measured using a dynamometer, expressed in kilograms (kg), with higher values indicating greater muscular strength.
Time frame: -1 week, 6 weeks, 12 weeks
Change in peak wattage during a work rate max test measured on a cycle ergometer.
Time frame: -1 week, 6 weeks, 12 weeks
Change in number of repetitions completed in 30 seconds.
Time frame: Time Frame: -1 week, 12 weeks
Change in total score across the three tests. The Short Performance Physical Battery (SPPB) is assessment of lower-extremity function in older adults, comprising balance, gait speed, and chair stand tests. Scores range from 0 to 12, with higher scores indicating better physical performance and mobility.
Time frame: week -1, week 12
Change in the average time taken to complete a 10-step stair climb expressed in seconds (s).
Time frame: week -1, week 12
Change in average forward reach distance for each arm expressed in centimeteres (cm).
Time frame: -1 week, 12 weeks
Change in mitochondrial respiration measured by high resolution respirometry (Oroboros Oxygraph-2k).
Time frame: -1 week, 6 weeks, and 12 weeks
Change in Canadian Longitudinal Study on Aging (CLSA) Frailty Index Score. The Canadian Longitudinal Study on Aging Frailty Index is a continuous measure from 0 to 1 calculated by dividing the number of health deficits present by the total number assessed, with higher values reflecting greater frailty. It is derived from a self-reported questionnaire covering 52 items, with each item representing a potential deficit.
Time frame: -1 week, 6 weeks, 12 weeks
Change in World Health Organization Five Well-Being Index Score (WHO-5). The World Health Organization Five Well-Being Index (WHO-5) is a self-reported questionnaire consisting of 5 items assessing subjective well-being. Each item is scored from 0 to 5, with total scores summed to a range of 0 to 25, where higher scores indicate better well-being.
Time frame: -1 week, 6 weeks, 12 weeks
Change in body height expressed in centimeters (cm).
Time frame: -1 week, 6 weeks, 12 weeks
Change in body weight measured in kilograms (kg).
Time frame: -1 week, 6 weeks, 12 weeks
Change in bioelectrical impedance analysis (BIA) estimated fat free mass measured in kilograms (kg).
Time frame: week -1, week 6, week 12
Change in bioelectrical impedance analysis (BIA) estimated body fat percentage.
Contact information is provided by the study sponsor or research team.
Dr. Chris McGlory, PhD
Other
Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults: A Randomized Controlled Pilot Feasibility Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07205133
Aging, Atrophy
Singapore
View Trial DetailsNCT07531836
Aging, Atrophy
Pamplona, Navarre, Spain
View Trial DetailsNCT07726498
Aging, Asthenia
Leicester, United Kingdom
View Trial DetailsNCT07275996
Aging, Atrophy
Burgos, Castille and León, Spain
View Trial Details